{
    "clinical_study": {
        "@rank": "38715", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine how many HIV-infected patients continue taking\n      ritonavir/indinavir combination after having taken indinavir three times a day as part of\n      their anti-HIV drug therapy. This study also examines the safety and effectiveness of the\n      ritonavir/indinavir combination."
        }, 
        "brief_title": "A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  CD4 cell count greater than 100 cells/microliter.\n\n          -  HIV RNA levels greater than 400 copies/microliter using the Roche Ultrasensitive\n             assay.\n\n          -  No acute illness.\n\n          -  Consent of parent or guardian if less than legal age.\n\n          -  No prior enrollment in this study.\n\n          -  All entry criteria for this study met within 15 days prior to enrollment.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with any of the following symptoms or conditions are excluded:\n\n        Any condition that in the opinion of the investigator may obscure proper observation of\n        the safety or activity of the treatment regimens used in this study.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Concurrent non-nucleoside reverse transcriptase inhibitors as part of the\n             antiretroviral regimen.\n\n          -  Any of the following medications with ritonavir:\n\n          -  midazolam, clorazepate, diazepam, estazolam, flurazepam, triazolam, zolpidem,\n             quinidine, amiodarone, encainide, flecainide, propafenone, bepridil, terfenadine,\n             astemizole, cisapride, bupropion, clozapine, rifabutin, meperidine, propoxyphene,\n             piroxicam, pimozide, dihydroergotamine, and ergotamine.\n\n          -  Any of the following medications with indinavir:\n\n          -  terfenadine, astemizole, cisapride, triazolam, midazolam. No requirement for rifampin\n             or ketoconazole.\n\n          -  Any concurrent treatment with other protease inhibitors.\n\n          -  Other concurrent medication (including over-the-counter medicine or alcohol) without\n             the knowledge and permission of the primary investigator.\n\n        Patients with the following prior conditions are excluded:\n\n          -  History of significant drug hypersensitivity.\n\n          -  Psychiatric illness that precludes compliance with the protocol.\n\n          -  Receipt of investigational drug within 30 days prior to administration of study drug.\n\n          -  History of acute or chronic pancreatitis.\n\n          -  Anticipation of poor patient compliance with protocol.\n\n        Prior Medication:\n\n        Excluded:\n\n        Prior treatment with ritonavir.\n\n        Risk Behavior:\n\n        Excluded:\n\n        History of active substance abuse (i.e., recreational drugs or alcohol).\n\n        Included:\n\n        - Indinavir 800 mg three times a day plus unspecified nucleosides for at least 3 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002223", 
            "org_study_id": "245E", 
            "secondary_id": "M98-823"
        }, 
        "intervention": [
            {
                "intervention_name": "Indinavir sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Ritonavir", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "HIV Protease Inhibitors", 
                "Indinavir", 
                "Ritonavir"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "Adolescent Behavior", 
            "HIV Protease Inhibitors", 
            "Ritonavir", 
            "Indinavir"
        ], 
        "lastchanged_date": "February 19, 2009", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027"
                    }, 
                    "name": "AIDS Healthcare Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Tower Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "Urgent Care Ctr / North Broward Hosp District"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maitland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32751"
                    }, 
                    "name": "Goodgame Med Ctr / Central Florida Research Initiati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Stephen Hauptman"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002223"
        }, 
        "source": "Abbott", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2009"
    }, 
    "geocoordinates": {
        "AIDS Healthcare Foundation": "34.052 -118.244", 
        "Goodgame Med Ctr / Central Florida Research Initiati": "28.628 -81.363", 
        "Mount Sinai Med Ctr": "40.714 -74.006", 
        "Stephen Hauptman": "39.952 -75.164", 
        "Tower Infectious Diseases": "34.052 -118.244", 
        "Urgent Care Ctr / North Broward Hosp District": "26.122 -80.143"
    }
}